Silyl-mediated photoredox-catalyzed Giese reaction: addition of non-activated alkyl bromides

被引:80
作者
ElMarrouni, Abdellatif [1 ]
Ritts, Casey B. [2 ]
Balsells, Jaume [2 ]
机构
[1] Merck & Co Inc, Dept Discovery Chem, MRL, 770 Sumneytown Pike, West Point, PA 19486 USA
[2] Merck & Co Inc, Dept Proc Res & Dev, MRL, 770 Sumneytown Pike, West Point, PA 19486 USA
关键词
ELECTRON-DEFICIENT ALKENES; SUBEROYLANILIDE HYDROXAMIC ACID; MEDICINAL CHEMISTS TOOLBOX; CONJUGATE ADDITION; RADICAL-ADDITION; HISTONE DEACETYLASES; ARYL HALIDES; ACTIVATION; GENERATION; ALCOHOLS;
D O I
10.1039/c8sc02253d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The emergence of photoredox catalysis has enabled the discovery of mild and efficient conditions for the generation of a variety of radical reaction platforms. Herein is disclosed the development of a conjugate addition reaction of non-activated alkyl bromides to Michael acceptors under visible-light photoredox catalysis. Optimization of the reaction was achieved using high-throughput experimentation (HTE) tools to enable the identification of mild, general and practical reaction conditions. A diverse set of alkyl bromides was successfully added to cyclic or acyclic alpha,beta-unsaturated esters and amides. The features of this transformation allowed also access to a key intermediate of Vorinostat (R), an HDAC inhibitor used to fight cancer and HIV.
引用
收藏
页码:6639 / 6646
页数:8
相关论文
共 70 条
[1]   Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy [J].
Archin, N. M. ;
Liberty, A. L. ;
Kashuba, A. D. ;
Choudhary, S. K. ;
Kuruc, J. D. ;
Crooks, A. M. ;
Parker, D. C. ;
Anderson, E. M. ;
Kearney, M. F. ;
Strain, M. C. ;
Richman, D. D. ;
Hudgens, M. G. ;
Bosch, R. J. ;
Coffin, J. M. ;
Eron, J. J. ;
Hazuda, D. J. ;
Margolis, D. M. .
NATURE, 2012, 487 (7408) :482-U1650
[2]  
Archin NM, 2017, J CLIN INVEST, V127, P3126, DOI [10.1172/jci92684, 10.1172/JCI92684]
[3]   TRIS(TRIMETHYLSILYL)SILANE AS A RADICAL-BASED REDUCING AGENT IN SYNTHESIS [J].
BALLESTRI, M ;
CHATGILIALOGLU, C ;
CLARK, KB ;
GRILLER, D ;
GIESE, B ;
KOPPING, B .
JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (02) :678-683
[4]  
Barton D. H. R., 1997, Org. Synth, V74, P101
[5]   Exploring DOXP-reductoisomerase binding limits using phosphonated N-aryl and N-heteroarylcarboxamides as DXR inhibitors [J].
Bodill, Taryn ;
Conibear, Anne C. ;
Mutorwa, Marius K. M. ;
Goble, Jessica L. ;
Blatch, Gregory L. ;
Lobb, Kevin A. ;
Klein, Rosalyn ;
Kaye, Perry T. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) :4332-4341
[6]  
Breslow R., 1993, PTC Int. Appl., Patent No. [WO93/07148, 9307148]
[7]   Advances in functional-group-tolerant metal-catalyzed alkyl-alkyl cross-coupling reactions [J].
Cárdenas, DJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (04) :384-387
[8]   Analysis of the reactions used for the preparation of drug candidate molecules [J].
Carey, John S. ;
Laffan, David ;
Thomson, Colin ;
Williams, Mike T. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (12) :2337-2347
[9]   The medicinal chemist's toolbox for late stage functionalization of drug-like molecules [J].
Cernak, Tim ;
Dykstra, Kevin D. ;
Tyagarajan, Sriram ;
Vachal, Petr ;
Krska, Shane W. .
CHEMICAL SOCIETY REVIEWS, 2016, 45 (03) :546-576
[10]   ORGANOSILANES AS RADICAL-BASED REDUCING AGENTS IN SYNTHESIS [J].
CHATGILIALOGLU, C .
ACCOUNTS OF CHEMICAL RESEARCH, 1992, 25 (04) :188-194